20 March 2017 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is scheduled to give initial opinions on the following initial applications:

• Fluciclovine (18F)
  
• Ivabradine hydrochloride
  
• Pentosan polysulphate sodium
  
• Nonacog beta pegol
  
• Meningococcal group B vaccine (recombinant, component, adsorbed)
  

Read agenda for March CHMP meeting